Farxiga, Xigduo XR Labeling Updated to Include Use in T2D Patients With Moderate Renal Impairment

Copyright © 2019 Haymarket Media, Inc. All Rights Reserved
This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.
Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms Conditions.

... read more at: https://www.empr.com/home/news/farxiga-xigduo-xr-labeling-updated-to-include-use-in-t2d-patients-with-moderate-renal-impairment/